Qu Fuyang, Zhao Shirui, Cheng Guangyao, Rahman Habibur, Xiao Qinru, Chan Renee Wan Yi, Ho Yi-Ping
Department of Biomedical Engineering, Faculty of Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
CUHK-UMCU Joint Research Laboratory of Respiratory Virus and Immunobiology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
Microsyst Nanoeng. 2021 May 24;7:38. doi: 10.1038/s41378-021-00267-w. eCollection 2021.
Multicellular spheroids have served as a promising preclinical model for drug efficacy testing and disease modeling. Many microfluidic technologies, including those based on water-oil-water double emulsions, have been introduced for the production of spheroids. However, sustained culture and the in situ characterization of the generated spheroids are currently unavailable for the double emulsion-based spheroid model. This study presents a streamlined workflow, termed the double emulsion-pretreated microwell culture (DEPMiC), incorporating the features of (1) effective initiation of uniform-sized multicellular spheroids by the pretreatment of double emulsions produced by microfluidics without the requirement of biomaterial scaffolds; (2) sustained maintenance and culture of the produced spheroids with facile removal of the oil confinement; and (3) in situ characterization of individual spheroids localized in microwells by a built-in analytical station. Characterized by microscopic observations and Raman spectroscopy, the DEPMiC cultivated spheroids accumulated elevated lipid ordering on the apical membrane, similar to that observed in their Matrigel counterparts. Made possible by the proposed technological advancement, this study subsequently examined the drug responses of these in vitro-generated multicellular spheroids. The developed DEPMiC platform is expected to generate health benefits in personalized cancer treatment by offering a pre-animal tool to dissect heterogeneity from individual tumor spheroids.
多细胞球体已成为一种很有前景的临床前药物疗效测试和疾病建模模型。许多微流控技术,包括基于水包油包水双乳液的技术,已被引入用于球体的生产。然而,基于双乳液的球体模型目前无法实现对所生成球体的持续培养和原位表征。本研究提出了一种简化的工作流程,称为双乳液预处理微孔培养(DEPMiC),它具有以下特点:(1)通过微流控产生的双乳液预处理有效启动均匀大小的多细胞球体,无需生物材料支架;(2)通过轻松去除油限制来持续维持和培养所产生的球体;(3)通过内置分析站对位于微孔中的单个球体进行原位表征。通过显微镜观察和拉曼光谱表征,DEPMiC培养的球体在顶膜上积累了升高的脂质有序性,类似于在其基质胶对应物中观察到的情况。由于所提出的技术进步而成为可能,本研究随后研究了这些体外生成的多细胞球体的药物反应。预计开发的DEPMiC平台将通过提供一种在动物实验前剖析单个肿瘤球体异质性的工具,为个性化癌症治疗带来健康益处。